Navigation Links
UofL infection prevention and control expert to influence national health-care leaders
Date:5/18/2011

A faculty member at the University of Louisville School of Public Health & Information Sciences has been selected to advise national healthcare leaders on infection control policy.

Ruth Carrico, PhD, is one of 14 experts appointed to a committee that will provide guidance to the director of the Centers for Disease Control and Prevention (CDC) and the secretary of the Department of Health and Human Services (HHS).

"I consider my appointment to the Healthcare Infection Control Practices Advisory Committee (HICPAC) a highlight of my professional career," Carrico said.

HICPAC provides advice and guidance on healthcare infection control practice, strategies for surveillance, and prevention and control of infections at facilities like hospitals and nursing homes. HICPAC also recommends new infection control guidelines and updates to current policies related to prevention of healthcare-associated infections like bloodstream or surgical site infections.

"Ruth's appointment represents true recognition for her knowledge and expertise by others in the field of infection prevention and control," said Richard Clover, MD, dean, UofL School of Public Health & Information Sciences.

Carrico has served as the editor of the Association for Professionals in Infection Control and Epidemiology (APIC) Text of Infection Control and Epidemiology, a textbook used to train infection prevention professionals since 2005. She also sits on the Certification Board of Infection Control and Epidemiology (CBIC), a voluntary multidisciplinary board that provides direction and administers the certification process for professionals in infection prevention and control and applied epidemiology.

During 2008-2010, Carrico also served on the National Biosurveillance Subcommittee, an advisory committee to the Director of the CDC. This committee was established following the 2007 Homeland Security Presidential Directive 21 (HSPD-21) that recognized the emergence of significant health-related threats to the nation. During her appointment, the committee provided counsel regarding the broad range of issues impacting the development and implementation of a nationwide biosurveillance strategy for human health.

She will sit on the Healthcare Infection Control Practices Advisory Committee until 2014.


'/>"/>

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville
Source:Eurekalert

Related biology news :

1. Hidden infections crucial to understanding, controlling disease outbreaks
2. New approach to treating cystic fibrosis lung infection shows promise
3. MU scientists see how HIV matures into an infection
4. Text focuses on diagnosing infections in immunocompromised patients
5. Biomarkers for identifying infant infections
6. Scientists discover bacteria that can cause bone infections
7. GUMC researchers hone in on new strategy to treat common infection
8. Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections
9. Battling bacteria in the blood: Researchers tackle deadly infections
10. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
11. Winter brings flu, summer brings bacterial infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , February 4, 2016 - New FDA action ... - New FDA action date of July 22, ... July 22, 2016   - ... in the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... to be held February 8-9, 2016, at the Waldorf ... Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ContraVir, ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
Breaking Biology Technology: